Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era

COVID-19 (Coronavirus Disease 2019), a life-threatening viral infection, is caused by a highly pathogenic virus named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Currently, no treatment is available for COVID-19; hence there is an urgent need to find effective therapeutic drugs to...

Descripción completa

Detalles Bibliográficos
Autores principales: Saini, Jasleen, Kaur, Pritpal, Malik, Naveen, Lakhawat, Sudarshan Singh, Sharma, Pushpender Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier GmbH. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491010/
https://www.ncbi.nlm.nih.gov/pubmed/36162150
http://dx.doi.org/10.1016/j.micres.2022.127206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491010/
https://www.ncbi.nlm.nih.gov/pubmed/36162150
http://dx.doi.org/10.1016/j.micres.2022.127206

Ejemplares similares